DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
3,3'-Diindolylmethane attenuates recognition memory impairment induced by binge ethanol exposure in mice
Binge drinking, defined as excessive alcohol consumption over a short period, is most common at ages that are particularly vulnerable to the harmful effects of alcohol. Cognitive functions are severely affected, and there is a concern that the consequences of alcohol consumption in early life stages can perpetuate into adulthood. 3,3'-Diindolylmethane (DIM) has recently been found to have neuroprotective activity. We aimed to investigate whether DIM could mitigate binge ethanol-induced memory deficits, and to explore the underlying mechanisms. Mice underwent four binge episodes spaced five days apart. Each episode consisted of three intraperitoneal ethanol injections (2.5, 2.5 and 2 g/kg) given at two-hour intervals. DIM (50 mg/kg/day, i.p) was administered during the last four days of the protocol, with the final dose being given 30 min prior to the first ethanol injection of the last binge episode. DIM attenuates the object recognition memory deficit induced by ethanol 20 h after the last exposure, an effect that can be sustained until 7 days if dosing is continued until testing. DIM increases the expression of the glutamate transporter EAAT2 and reduces the ethanol-induced disruption of the GluN2A/GluN2B receptor ratio but does not alter the ethanol-induced increase in AMPA receptor membrane trafficking. DIM reduces the ethanol induced-increase in MMP-9 activity and facilitates the survival of immature neurons without modifying the ethanol-induced decrease in mature neurons nor the increase in microglia. DIM may be a promising therapeutic candidate for ethanol-induced memory deficits through modulation of glutamatergic neurotransmission, hippocampal neurogenesis and MMP-9 activity., This study was supported by grants from Ministerio de Economía y Competitividad and Ministerio de Ciencia e Innovación (PID2019-105847RB-100 and PID2022-142137OB-I00), Ministerio de Sanidad, Servicios Sociales e Igualdad [Plan Nacional Sobre Drogas (PNSD) Grants 2017I017, 2022I033 and 2023I029], Instituto de Salud Carlos III Redes Temáticas de Investigación Cooperativa en Salud − Red de Trastornos Adictivos (RETICS-RTA) Grant RD16/0017/0021 and Redes de Investigación Cooperativa Orientadas a Resultados en Salud − Red de Investigación en Atención Primaria de Adicciones (RICORS-RIAPAd) Grant RD21/0009/0027, with funds from the European Union (Fondo Europeo de Desarrollo Regional FEDER). NMP and CNC were funded by Personal Investigador en Formación fellowships from Universidad Complutense de Madrid. LGBE and MPH were funded by FPI fellowships from Ministerio de Ciencia e Innovación. PGG was funded by a FPU fellowship from Ministerio de Educación., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-105847RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-142137OB-I00
,
MINECO RD16-0017-0021
DOI: http://hdl.handle.net/10261/418003, https://api.elsevier.com/content/abstract/scopus_id/105024806996
HANDLE: http://hdl.handle.net/10261/418003, https://api.elsevier.com/content/abstract/scopus_id/105024806996